Pharma Industry News
New Hair Data Validate Sharp Downward Trend in Cocaine and Methamphetamine Positivity in General U.S. Workforce, According to Quest Diagnostics Drug Testing Index(TM)
MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- New data released today by Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of employment-related drug testing services, reveal that drug testing of hair specimens from employees and job applicants in the general U.S.
Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
PRINCETON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has formed a consortium to develop thermostable technology to advance RiVax(TM) and other rapidly acting vaccines.
Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries
MEMPHIS, Tenn., Nov. 20 /PRNewswire-FirstCall/ -- Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedics Division is pleased to announce the signing of a technology development contract with the United States Department of Defense that may lead to the creation of a fracture fixation system intended to revolutionize the treatment of the limbs of soldiers who sustain battlefield injuries.
FDA Issues 22 Warning Letters To Web Site Operators
The U.S. Food and Drug Administration completed a coordinated, weeklong, international effort, called the International Internet Week of Action (IIWA), intended to curb illegal actions involving medical products.
FDA Issues 22 Warning Letters To Web Site Operators
The U.S. Food and Drug Administration completed a coordinated, weeklong, international effort, called the International Internet Week of Action (IIWA), intended to curb illegal actions involving medical products.
US nod for a generic drug lifts Ranbaxy Laboratories
US nod for a generic drug lifts Ranbaxy Laboratories
India Infoline.com - 1 hour ago
On BSE, 2.22 lakh shares were traded in the counter as against an average daily volume of 5.31 lakh shares in the past one quarter. The stock had hit a high of Rs 421.80 and a low of Rs 412 so far ...
Adamas Pharmaceuticals Expands Clinical Study For Triple-Combination Antiviral Drug Therapy In Immune Compromised Patients
Adamas Pharmaceuticals, Inc., a privately held company, announced that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States, Canada and Europe.
Circassia Announces Successful Results From Phase II Clinical Study of ToleroMune(R) Cat Allergy Therapy
OXFORD, England, November 20 /PRNewswire/ -- Circassia Ltd, a specialty
biopharmaceutical company focused on allergy, today announced positive
results from a recently completed phase II clinical study of its
ToleroMune(R) cat allergy therapy, which successfully identified the optimal
dosing regimens to progress into late-stage development.
Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group
SEATTLE, Nov. 20 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled that CTI should be allowed to pursue all of its claims against The Lash Group, sending the case back to the District Court for trial.
Pfizer Announces FDA Advisory Committee Finds Data Support Claim That SPIRIVA HandiHaler Reduces COPD Exacerbations
Pfizer Announces FDA Advisory Committee Finds Data Support Claim That SPIRIVA HandiHaler Reduces COPD Exacerbations
Reuters Key Development - 1 hour ago
